Vitiligo trials in Taiwan

1 of 2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

  Where

  Kaohsiung City, Taoyuan

  Age

  18 years to 65 years

  People

  45 worldwide

  Run by

  Elixiron Immunotherapeutics (Hong Kong) Ltd.

  See details and how to joinNCT07223229